HomeFilePeripheral vascular disease

Peripheral vascular disease

SOLACI-SOCIME 2022 | Rol de los Dispositivos Fenestrados en Hipertensión Arterial Pulmonar, by Dr. Daniel Springmuller

Read the most outstanding articles from the second day of the SOLACI-SOCIME 2022 Congress. In this case, consult...

SOLACI-SOCIME 2022 | Pulsta Valve implantation : How do I do it?, by Dr. Alejandro Peirone

Read the most outstanding articles from the second day of the SOLACI-SOCIME 2022 Congress. In this case, consult...

SOLACI-SOCIME 2022 | Surgical Pulmonary Valve Replacement, by Dr. Jorge Cervantes Salazar

Read the most outstanding articles from the second day of the SOLACI-SOCIME 2022 Congress. In this case, consult...

Renal Guard System to Prevent Contrast Induced Acute Kidney Injury in Patients at High Risk Contrast Induced Acute Kidney Injury

Contrast Induced Acute Kidney Injury (CI-AKI) is associated to increased costs and unfavorable results after hemodynamic procedures....

DISRUPT-PAD III: Followup of IVL Treatment in Femoropopliteal Territory

Femoropopliteal segment calcification can generate complications for both preparation and execution of endovascular therapies for patients with...

Are Elevated Lipoprotein (a) Levels Associated with Increased Adverse Events After Peripheral Endovascular Treatment?

Peripheral arterial disease is a manifestation of systemic atherosclerotic disease with increasing prevalence. Moreover, this disease is...

Thromboendarterectomy vs. Endovascular Therapy in Common Femoropopliteal Territory. Is Surgery Still the Gold Standard?

For lesions in the common femoral artery, guidelines recommend surgical endarterectomy (TEA) as the gold standard. However,...

Intermittent Claudication: Invasive Treatment Superior to Pharmacological Treatment?

Peripheral vascular disease is strongly associated to cardiovascular events and a negative impact on health status and...